Market Place
Sourcing Support
AtomVie And Radiopharm Partner On Radioantibody for Multiple Solid Tumors
15 Oct 2024 //
PR NEWSWIRE
Deutsche Bank Appointed As Depositary For Radiopharm ADR
19 Sep 2024 //
BUSINESSWIRE
Radiopharm Receives Strategic Investment for up to A$18 million
20 Jun 2024 //
GLOBENEWSWIRE
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody
09 Oct 2023 //
GLOBENEWSWIRE
Radiopharm Expands Supply Agreement With TerThera for Terbium-161 Isotope
24 Aug 2023 //
GLOBENEWSWIRE
Radiopharm Receives FDA Orphan Drug Designation for Trivehexin (RAD 301)
09 May 2023 //
GLOBENEWSWIRE
Radiopharm Enters Into Supply Agreement with TerThera for Terbium-161 Isotope
17 Apr 2023 //
GLOBENEWSWIRE
Radiopharm Invited to Participate in Jefferies Radiopharma Innovation Summit
28 Mar 2023 //
GLOBENEWSWIRE
Dr Ken Herrmann Appointed to RAD Scientific Advisory Board
03 Mar 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics Partners With Next Generation Preclinical Platform
03 Mar 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics Initiates Process for Nasdaq Listing
14 Feb 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics inks pact with NorthStar Medical Radioisotopes supply
27 Oct 2022 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.